Riddhi Siddhi Gluco Biols ‘s Q2 Financial results: Revenue Grows by 169.69% YoY

The comprehensive analytics outlining the performance and outlook of Riddhi Siddhi Gluco Biols Ltd‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Riddhi Siddhi Gluco Biols Ltd’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 169.69 %. However, it did see a marginal increase of 242.86 % from the previous quarter. Expenses ticked up slightly by 193.44 % quarter-on-quarter, aligning with the annual rise of 194.86 %. Operating profit, while up 72.31 % compared to last year, faced a quarter-on-quarter increase of 3013.64 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -7.41 %, but an expansion of 14.65 % sequentially. Other income rose by 5.27 % compared to the last quarter, despite an annual decline of -6.15 %. Interest expenses surged remarkably by 66.48 % from the previous quarter, yet the year-over-year increase remains at a moderate 6.55 %. Depreciation costs fell by -6.85 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -25 %. Profit before tax grew annually by 8.62 % but saw an increase from the preceding quarter by 41.75 %.
Tax expenses as a percentage of profits decreased slightly by -9.21 % compared to last year, with a more notable quarter-on-quarter decrease of -30.53 %. Net profit rose by 35.88 % year-on-year but witnessed a -44.2 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 35.9 % but a quarterly fall of -44.18 %. In summary, Riddhi Siddhi Gluco Biols Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Riddhi Siddhi Gluco Biols Ltd’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 169.69 % year-on-year growth, however, there was a minor increase of 242.86 % from the previous quarter. Expenses rose by 194.86 % compared to the previous year, with a 193.44 % increase quarter-on-quarter. Operating Profit surged by 72.31 % annually, and saw a 3013.64 % increase from the last quarter.
Net Profit showed yearly increase of 35.88 %, and experienced a -44.2 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 35.9 % annually, however dipped by -44.18 % compared to the last quarter. In essence, while Riddhi Siddhi Gluco Biols Ltd exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.